Long-Lasting Responses After Discontinuation of Nivolumab Treatment for Reasons Other Than Tumor Progression in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer
Cancer Communications - United Kingdom
doi 10.1186/s40880-019-0423-3
Full Text
Open PDFAbstract
Available in full text
Date
November 21, 2019
Authors
Publisher
Wiley